Harvard Study: Free Spike Protein - Not Bound by Antibodies - Detected in the Blood of Adolescents and Young Adults Who Developed Post-mRNA Vaccine Myocarditis

Free Spike in the blood does not bode well for human health. I think it explains the atypical fibrous clots - hands down.

When we we sold the bill of goods on mRNA vaccines, we were told the stream of material injected into people would stay at the injection site. We found out via early Japanese biodistribution studies that the mRNA itself circulated to and could enter basically any and all cells in the body, including our brain.

A new study found that spike protein itself - produced by our cells - is, in fact, circulating freely in the blood of adolescents and young adults who developed myocarditis following mRNA injections.

The rubbery clots being found in both arteries and veins make a lot of sense now, given that spike protein can form syncytia - fused cells - and our blood is teeming with all sorts of cells that express ACE2, including vascular cells shed from the lining of blood vessels and platelets. I expect that the clots will be found to be contain the dead, dying and still alive cells connected to each other in strands and fibers - along with fibrin, with insufficient fibronectin.

This process could take a long time, and could explain the finding my Mike Adams of the lack of iron in the clots back in October 2022 (See:EPOCH TIMES, Natural News)

Here’s the abstract and the link to the study

Abstract

BACKGROUND:

Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–targeted mRNA vaccines have been reported globally, but the underlying immunoprofiles of these individuals have not been described in detail.

METHODS:

From January 2021 through February 2022, we prospectively collected blood from 16 patients who were hospitalized at Massachusetts General for Children or Boston Children’s Hospital for myocarditis, presenting with chest pain with elevated cardiac troponin T after SARS-CoV-2 vaccination. We performed extensive antibody profiling, including tests for SARS-CoV-2–specific humoral responses and assessment for autoantibodies or antibodies against the human-relevant virome, SARS-CoV-2–specific T-cell analysis, and cytokine and SARS-CoV-2 antigen profiling. Results were compared with those from 45 healthy, asymptomatic, age-matched vaccinated control subjects.

RESULTS:

Extensive antibody profiling and T-cell responses in the individuals who developed postvaccine myocarditis were essentially indistinguishable from those of vaccinated control subjects, despite a modest increase in cytokine production. A notable finding was that markedly elevated levels of full-length spike protein (33.9±22.4 pg/mL), unbound by antibodies, were detected in the plasma of individuals with postvaccine myocarditis, whereas no free spike was detected in asymptomatic vaccinated control subjects (unpaired t test; P<0.0001). (emphasis by PR).

CONCLUSIONS:

Immunoprofiling of vaccinated adolescents and young adults revealed that the mRNA vaccine–induced immune responses did not differ between individuals who developed myocarditis and individuals who did not. However, free spike antigen was detected in the blood of adolescents and young adults who developed post-mRNA vaccine myocarditis, advancing insight into its potential underlying cause.

Citation:

Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, Davis JP, Loiselle M, Novak T, Senussi Y, Cheng CA, Burgess E, Edlow AG, Chou J, Dionne A, Balaguru D, Lahoud-Rahme M, Arditi M, Julg B, Randolph AG, Alter G, Fasano A, Walt DR. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. Circulation. 2023 Jan 4. doi: 10.1161/CIRCULATIONAHA.122.061025. Epub ahead of print. PMID: 36597886.